InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-0.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by ROGERS MICHAEL W, Director. Director active across 1 company, notably Akebia Therapeutics, Inc.. Cumulatively, 6 disclosures have been published. Activity tracked since 2 June 2021. The latest transaction was filed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
35,700 sharesCommon StockSEC:0001244159-26-000001:0
30,000 shares0Common StockSEC:0001562180-24-004907:0
30,000 shares0Common StockSEC:0001562180-23-004959:0
13,700 shares0Common StockSEC:0001562180-22-004976:0
13,700 shares0Common StockSEC:0001562180-21-004029:0
13,700 shares0Common StockSEC:0001562180-21-004029
6 of 6 declarations
About ROGERS MICHAEL W
Michael W. Rogers is a Director at Akebia Therapeutics, Inc. As a board member, he participates in the governance of the company and in strategic decision-making. Akebia Therapeutics is a biopharmaceutical company focused on developing innovative treatments for kidney diseases. Michael W. Rogers brings valuable experience in the sector, contributing to the strategic direction of the company.
